New /sup 111/In-bleomycin complex for combined radiotherapy and chemotherapy
Journal Article
·
· J. Surg. Oncol.; (United States)
Six days after tumor transplantation three daily intraperitoneal doses of 0.9% NaCl, bleomycin (BLM), or a new 111In-bleomycin complex (BLMC, 15 microCi/g body weight) were administered to glioma-bearing mice. After therapy, tumors in mice treated with /sup 111/In-BLMC were smaller than those treated with BLM. Sixteen days after the first injection tumor size for /sup 111/In-BLMC-treated mice was 560 (240-1,030) mm3, 1980 (1400-3290) mm3 for BLM (P less than 0.025), and 4830 (2580-9180) mm3 for NaCl (0.1 less than P less than 0.2). Thirteen days after tumor transplantation glioma-bearing mice received single intratumor injection of 0.9% NaCl, BLM, or /sup 111/In-BLMC (1.5 mCi, carried by 0.5 mg BLM/g tumor weight). The average tumor size for /sup 111/In-BLMC was smaller than that for BLM by a factor of 2.5-3.7. Host weights for these two groups were similar, and morphologic abnormalities were not found in kidney or liver.
- Research Organization:
- National Institutes of Health, Bethesda, MD
- OSTI ID:
- 5684730
- Journal Information:
- J. Surg. Oncol.; (United States), Journal Name: J. Surg. Oncol.; (United States) Vol. 2; ISSN JSONA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Use of /sup 111/In-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice
A new 111In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice
New tumor imaging agent--/sup 111/In-bleomycin complex. Comparison with /sup 67/Ga-citrate and /sup 57/Co-bleomycin in tumor-bearing animals
Journal Article
·
Sat Jun 01 00:00:00 EDT 1985
· J. Surg. Oncol.; (United States)
·
OSTI ID:5802073
A new 111In-bleomycin complex for tumor imaging: preparation, stability, and distribution in glioma-bearing mice
Journal Article
·
Wed Feb 29 23:00:00 EST 1984
· J. Surg. Oncol.; (United States)
·
OSTI ID:7138242
New tumor imaging agent--/sup 111/In-bleomycin complex. Comparison with /sup 67/Ga-citrate and /sup 57/Co-bleomycin in tumor-bearing animals
Journal Article
·
Wed Oct 31 23:00:00 EST 1984
· J. Surg. Oncol.; (United States)
·
OSTI ID:5969649
Related Subjects
550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
560162* -- Radionuclide Effects
Kinetics
& Toxicology-- Animals
Plants
Microorganisms
& Cells
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMALS
ANTI-INFECTIVE AGENTS
ANTIBIOTICS
ANTIMITOTIC DRUGS
ANTINEOPLASTIC DRUGS
BETA DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL MODELS
BIOLOGICAL RADIATION EFFECTS
BLEOMYCIN
DAYS LIVING RADIOISOTOPES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EXPERIMENTAL NEOPLASMS
GLIOMAS
INDIUM 111
INDIUM ISOTOPES
INTERMEDIATE MASS NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MAMMALS
MEDICINE
MICE
MINUTES LIVING RADIOISOTOPES
NECROSIS
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
PATHOLOGICAL CHANGES
RADIATION EFFECTS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RODENTS
TESTING
THERAPY
VERTEBRATES
WEIGHT
560162* -- Radionuclide Effects
Kinetics
& Toxicology-- Animals
Plants
Microorganisms
& Cells
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMALS
ANTI-INFECTIVE AGENTS
ANTIBIOTICS
ANTIMITOTIC DRUGS
ANTINEOPLASTIC DRUGS
BETA DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL MODELS
BIOLOGICAL RADIATION EFFECTS
BLEOMYCIN
DAYS LIVING RADIOISOTOPES
DISEASES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EXPERIMENTAL NEOPLASMS
GLIOMAS
INDIUM 111
INDIUM ISOTOPES
INTERMEDIATE MASS NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MAMMALS
MEDICINE
MICE
MINUTES LIVING RADIOISOTOPES
NECROSIS
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
PATHOLOGICAL CHANGES
RADIATION EFFECTS
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RODENTS
TESTING
THERAPY
VERTEBRATES
WEIGHT